期刊名称：PLOS NEGLECTED TROPICAL DISEASES
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
PLoS Neglected Tropical Diseases is an open access journal devoted to the pathology, epidemiology, prevention, treatment and control of the neglected tropical diseases (NTDs), as well as public policy relevant to this group of diseases. The NTDs are defined as a group of poverty-promoting chronic infectious diseases, which primarily occur in rural areas and poor urban areas of low-income and middle-income countries. They are poverty-promoting because of their impact on child health and development, pregnancy, and worker productivity, as well as their stigmatizing features.
Instructions to Authors
PLoS Neglected Tropical Diseases publishes original research articles of importance to the NTDs community and the wider health community. We will consider manuscripts of any length; we encourage the submission of both substantial full-length bodies of work and shorter manuscripts that report novel findings that might be based on a more limited range of experiments.
The writing style should be concise and accessible, avoiding jargon so that the paper is understandable for readers outside a specialty or those whose first language is not English. Editors will make suggestions for how to achieve this, as well as suggestions for cuts or additions that could be made to the article to strengthen the argument. Our aim is to make the editorial process rigorous and consistent, but not intrusive or overbearing. Authors are encouraged to use their own voice and to decide how best to present their ideas, results, and conclusions. Although we encourage submissions from around the globe, we require that manuscripts be submitted in English. Authors who do not use English as a first language may contact us for additional information. As a step towards overcoming language barriers on acceptance of the paper, we encourage authors fluent in other languages to provide copies of their full articles or abstracts in other languages. We will publish these translations as supporting information and list them, together with other supporting information files, at the end of the article text.
Cover Letter
Please include a cover letter explaining why this manuscript is suitable for publication in PLoS Neglected Tropical Diseases. Why will your research paper inspire the NTDs community, and how will it drive the understanding of NTD pathobiology, epidemiology, prevention, treatment, control, or policy?
If your study addresses an infection that is outside our detailed scope, you must first send a pre-submission inquiry indicating why you consider the infection to be a neglected tropical disease.
Electronic Formats
Our submission system supports a limited range of formats for text and graphics. The following file formats/types and manuscript information are required before submission. If you are concerned about the suitability of your files, please contact us at plosntds [at] plos.org.
Manuscript and Table Files
Microsoft Word article files should be submitted in DOC or RTF format. For technical reasons PLoS cannot accept Word 2007 DOCX files. If you created your manuscript using Word 2007, you must save the document as a Word 2003 file before submission.
Math Equations and Word 2007
If you are using Word 2007 and your manuscript will contain equations, you must follow the instructions below to make sure that your equations will be editable when you save the file as a Word 2003 document. PLoS cannot accept articles containing equations that are not editable in Word 2003.
You can ensure that your equations remain editable in Word 2003 by enabling "Compatibility Mode" before you begin. To do this:
Open a new document.
Save as "Word 97-2003 Document (*.doc)."
Several features of Word 2007 will now be inactive, including the built-in equation editing tool. You can now insert equations in one of two ways:
Go to Insert > Object > Microsoft Equation 3.0 and create the equation.
Use MathType to create the equation. MathType is the recommended method for creating equations.
If, when saving your final document, you see a message saying "Equations will be converted to images". This means that your equations are no longer editable and PLoS will not be able to accept your file.
NOTE: If you have already composed your article in Word 2007 and used its built-in equation editing tool, your equations will become images when the file is saved down to Word 97-2003. You will need to edit your document and insert the equations using one of the two ways specified above.
LaTeX
Articles prepared in LaTeX may be submitted in PDF format for use during the review process. After acceptance, however, .tex files and formatting information will be required as a zipped file. Please consult our LaTeX Guidelines for a list of what will be required.
Tables
Tables must conform to our Guidelines for Figure and Table Preparation and placed at the end of the article DOC or RTF file. Accepted LaTeX submissions only should have table files—which must also conform to these guidelines—uploaded individually into the online submission system.
Figure Files
Graphics files can only be submitted in EPS or TIF format. For the article to be accepted for publication, the author will need to supply high-resolution versions of the figures. When preparing your figures, please ensure that the files conform to our Guidelines for Table and Figure Preparation.
If you are uploading your files in EPS format, please use the "create outlines" option under the type menu in Illustrator so that all text and fonts appear as intended in print. If you need additional help with figure preparation, please contact figures [at] plos.org.
Authors are encouraged to provide a striking image to accompany their article, if one is available. This image may be chosen to highlight the article on our journal Web site.
PLoS does not accept vector EPS figures generated using LaTeX. We only accept LaTeX generated figures in TIFF format. Export your LaTeX files as PDFs, and then open them in GIMP or Photoshop and save as TIFF. In general, Figures must be generated in a standalone graphics application such as Adobe Illustrator, InkScape, PyMol, MatLab, SAS, etc. Please see our Figure Guidelines for more information.
All figures will be published under a Creative Commons Attribution License. Upon publication they will be made available online without cost to anyone, anywhere—to download, redistribute, include in databases, and otherwise use—subject only to the condition that the original authorship is properly attributed. Please do not submit any figures that have been previously copyrighted unless you have express written permission from the copyright holder to publish under this license.
Financial Disclosure
This section should describe sources of funding that have supported the work. Please include relevant grant numbers and the URL of any funder's Web site. Please also include this sentence: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct, you must describe the role of any sponsors or funders, and amend the aforementioned sentence as needed.
Competing Interests
The submitting author is asked at submission to declare, on behalf of all authors, whether there are any financial, personal, or professional interests that could be construed to have influenced the paper. The information entered here will appear in the published version, so please do not include the same in the manuscript file.
Reviewers are also asked to declare any interests that might interfere with their objective assessment of a manuscript. Any relevant competing interests of authors must be available to editors and reviewers during the review process and will be stated in published articles. Read more about the Public Library of Science's Competing Interests Policy.
Abbreviations
Please keep abbreviations to a minimum and define them upon first use in the text. Non-standard abbreviations should not be used unless they appear at least three times in the text.
Nomenclature
The use of standardized nomenclature in all fields of science and medicine is an essential step toward the integration and linking of scientific information reported in published literature. We will enforce the use of correct and established nomenclature wherever possible:
We strongly encourage the use of SI units. If you do not use these exclusively, please provide the SI value in parentheses after each value.
Species names should be italicized (e.g., Homo sapiens) and the full genus and species must be written out in full, both in the title of the manuscript and at the first mention of an organism in a paper; after that, the first letter of the genus name, followed by the full species name may be used.
Genes, mutations, genotypes, and alleles should be indicated in italics. Use the recommended name by consulting the appropriate genetic nomenclature database, e.g., HUGO for human genes. It is sometimes advisable to indicate the synonyms for the gene the first time it appears in the text. Gene prefixes such as those used for oncogenes or cellular localization should be shown in roman: v-fes, c-MYC, etc.
The Recommended International Non-Proprietary Name (rINN) of drugs should be provided.
Accession Numbers
All appropriate datasets, images, and information should be deposited in public resources. Please provide the relevant accession numbers (and version numbers, if appropriate). Accession numbers should be provided in parentheses after the entity on first use. Suggested databases include, but are not limited to:
ArrayExpress
BioModels Database
Database of Interacting Proteins
DNA Data Bank of Japan [DDBJ]
DRYAD
EMBL Nucleotide Sequence Database
GenBank
Gene Expression Omnibus [GEO]
Protein Data Bank
UniProtKB/Swiss-Prot
ClinicalTrials.gov
In addition, as much as possible, please provide accession numbers or identifiers for all entities such as genes, proteins, mutants, diseases, etc., for which there is an entry in a public database, for example:
Ensembl
Entrez Gene
FlyBase
InterPro
Mouse Genome Database (MGD)
Online Mendelian Inheritance in Man (OMIM)
PubChem
Providing accession numbers allows linking to and from established databases and integrates your article with a broader collection of scientific information.
Organization of the Manuscript
Most articles published in PLoS Neglected Tropical Diseases are organized into the following sections: Title, Authors and Affiliations, Abstract, Author Summary, Introduction, Methods, Results, Discussion, Acknowledgments, References, Figure Legends, and Tables. Uniformity in format facilitates the experience of readers and users of the journal. To provide flexibility, however, the Results and Discussion can be combined into one Results/Discussion section. All manuscripts must contain line numbers. Although we have no firm length restrictions for the entire manuscript, we urge authors to present and discuss their findings concisely.
Templates for Specific Study Types
Clinical Research article
Clinical Trial article
Systematic Review / Meta-Analysis article
These manuscript templates will help to prepare your manuscript in the standard format. The templates consist of the standard headings along with body text explaining what to include in each section. You should overwrite (or copy and paste) the body text with the corresponding section text for your article.
Title (150 characters)
The title should be specific to the study yet concise, and should allow sensitive and specific electronic retrieval of the article. It should be comprehensible to readers outside your field. Avoid specialist abbreviations if possible. Titles should be presented in title case, meaning that all words except for prepositions, articles, and conjunctions should be capitalized. If the paper is a randomized controlled trial or a meta-analysis, this description should be in the title.
Examples:
Climate Change and Spread of Lymphatic Filariasis in Sub-Saharan Africa
A Cluster-Randomized Controlled Trial of a Nurse-Led Deworming Program for Soil-Transmitted Helminths
Please also provide a brief Short Title of no more than 50 characters (including spaces).
Authors and Affiliations
Provide the first names or initials (if used), middle names or initials (if used), surnames, and affiliations—department, university or organization, city, state/province (if applicable), and country—for all authors. One of the authors should be designated as the corresponding author. It is the corresponding author's responsibility to ensure that the author list, and the summary of the author contributions to the study are accurate and complete. If the article has been submitted on behalf of a consortium, all consortium members and affiliations should be listed after the Acknowledgments.
(For authorship criteria, see Supporting Information and Materials Required at Submission)
Abstract
The abstract succinctly introduces the paper. We advise that it should not exceed 250 – 300 words. It should mention the techniques used without going into methodological detail and summarize the most important results with important numerical results given. The abstract is conceptually divided into the following three sections with these headings: Background, Methodology/Principal Findings, and Conclusions/Significance. Please do not include any citations in the abstract. Avoid specialist abbreviations.
Author Summary
We ask that all authors of research articles include a 150- to 200-word non-technical summary of the work, immediately following the Abstract. Subject to editorial review and author revision, this short text is published with all research articles as a highlighted text box.
Distinct from the scientific abstract, the author summary should highlight where the work fits in a broader context of life science knowledge and why these findings are important to an audience that includes both scientists and non-scientists. Ideally aimed to a level of understanding of an undergraduate student, the significance of the work should be presented simply, objectively, and without exaggeration.
Authors should avoid the use of acronyms and complex scientific terms and write the author summary using the first-person voice. Authors may benefit from consulting with a science writer or press officer to ensure that they effectively communicate their findings to a general audience.
Examples are available at:
Pseudogenization of a Sweet-Receptor Gene Accounts for Cats' Indifference toward Sugar
A Hybrid Photoreceptor Expressing Both Rod and Cone Genes in a Mouse Model of Enhanced S-Cone Syndrome
Life in Hot Carbon Monoxide: The Complete Genome Sequence of Carboxydothermus hydrogenoformans Z-2901
Introduction
The introduction should discuss the purpose of the study in the broader context. As you compose the introduction, think of readers who are not experts in this field. Include a brief review of the key literature. If there are relevant controversies or disagreements in the field, they should be mentioned so that a non-expert reader can delve into these issues further. The introduction should conclude with a brief statement of the overall aim of the experiments and a comment about whether that aim was achieved.
Methods
This section should provide enough detail for reproduction of the findings. Protocols for new methods should be included, but well-established protocols may simply be referenced. Detailed methodology or supporting information relevant to the methodology can be published on our Web site.
This section should also include a section with descriptions of any statistical methods employed. These should conform to the criteria outlined by the Uniform Requirements, as follows: "Describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Avoid relying solely on statistical hypothesis testing, such as the use of P values, which fails to convey important quantitative information. Discuss the eligibility of research participants. Give details about randomization. Describe the methods for and success of any blinding of observations. Report complications of treatment. Give numbers of observations. Report losses to observation (such as dropouts from a clinical trial). References for the design of the study and statistical methods should be to standard works when possible (with pages stated) rather than to papers in which the designs or methods were originally reported. Specify any general-use computer programs used."
Results
The results section should include all relevant positive and negative findings. The section may be divided into subsections, each with a concise subheading. Large datasets, including raw data, should be submitted as supporting files; these are published online alongside the accepted article. The results section should be written in past tense.
As outlined in the Uniform requirements, authors that present statistical data in the Results section, should "...specify the statistical methods used to analyze them. Restrict tables and figures to those needed to explain the argument of the paper and to assess its support. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables. Avoid nontechnical uses of technical terms in statistics, such as "random" (which implies a randomizing device), "normal," "significant," "correlations," and "sample." Define statistical terms, abbreviations, and most symbols."
Discussion
The discussion should be concise and tightly argued. It should start with a brief summary of the main findings. It should include paragraphs on the generalisability, clinical relevance, strengths, and, most importantly, the limitations of your study. You may wish to discuss the following points also. How do the conclusions affect the existing knowledge in the field? How can future research build on these observations? What are the key experiments that must be done?
Acknowledgments
People who contributed to the work, but do not fit the criteria for authors should be listed in the Acknowledgments, along with their contributions. You must also ensure that anyone named in the acknowledgments agrees to being so named.
Details of the funding sources that have supported the work should be confined to the funding statement provided in the online submission system. Do not include them in the acknowledgments.
References
Only published or accepted manuscripts should be included in the reference list. Meetings abstracts, conference talks, or papers that have been submitted but not yet accepted should not be cited. Limited citation of unpublished work should be included in the body of the text only. All personal communications should be supported by a letter from the relevant authors.
Download EndNote output style file for EndNote 8 and above or EndNote 4-7 (right-click the link to download the file to your computer)
Download BibTeX style file (right-click the link to download the file to your computer)
PLoS uses the numbered citation (citation-sequence) method. References are listed and numbered in the order that they appear in the text. In the text, citations should be indicated by the reference number in brackets. Multiple citations within a single set of brackets should be separated by commas. Where there are three or more sequential citations, they should be given as a range. Example: "... has been shown previously [1,4-6,22]." Make sure the parts of the manuscript are in the correct order before ordering the citations.
Because all references will be linked electronically as much as possible to the papers they cite, proper formatting of the references is crucial. Please use the following style for the reference list:
Published Papers
1. Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74: 5463-5467.
Please list the first five authors and then add "et al." if there are additional authors. Use of a DOI number for the full-text article is acceptable as an alternative to or in addition to traditional volume and page numbers.
Accepted Papers
Same as above, but "in press" appears instead of the page numbers. Example: Adv Clin Path. In press.
Electronic Journal Articles 1. Loker WM (1996) "Campesinos" and the crisis of modernization in Latin America. Jour Pol Ecol 3. Available: http://www.library.arizona.edu/ej/jpe/volume_3/ascii-lokeriso.txt. Accessed 2006 Aug 11.
Books
1. Bates B (1992) Bargaining for life: A social history of tuberculosis. Philadelphia: University of Pennsylvania Press. 435 p.
Book Chapters
1. Hansen B (1991) New York City epidemics and history for the public. In: Harden VA, Risse GB, editors. AIDS and the historian. Bethesda: National Institute of Health. pp. 21-28.
Figure Legends
The aim of the figure legend should be to describe the key messages of the figure, but the figure should also be discussed in the text. An enlarged version of the figure and its full legend will often be viewed in a separate window online, and it should be possible for a reader to understand the figure without switching back and forth between this window and the relevant parts of the text. Each legend should have a concise title of no more than 15 words that can stand alone, without the use of figure part labels. The overall legend itself should be succinct, while still explaining all figure parts, symbols, and abbreviations. Avoid lengthy descriptions of methods.
Tables
All tables should have a concise title. Footnotes can be used to explain abbreviations. Citations should be indicated using the same style as outlined above. Tables should not occupy more than one printed page; larger tables can be published as online supporting information. Tables must be cell-based; do not use picture elements, text boxes, tabs, or returns in tables. Please ensure that the files conform to our Guidelines for Figure and Table Preparation when preparing your tables for production.
Tables should be placed at the end of the manuscript file, rather than uploaded separately into the submission system.
Multimedia Files and Supporting Information
We encourage authors to submit essential supporting files and multimedia files along with their manuscripts. All supporting material will be subject to peer review, and should be smaller than 10 MB in size because of the difficulties that some users will experience in loading or downloading files of a greater size.
Supporting files should fall into one of the following categories: Dataset, Figure, Table, Text, Protocol, Audio, or Video. All supporting information should be referred to in the manuscript with a leading capital S (e.g., Figure S4 for the fourth supporting information figure). The numbered title and caption for each supporting information file should be included in the main article file, after the titles and captions for the main figures.
Supporting files may be submitted in a variety of formats, but should be publication-ready, as these files are not copyedited. Carefully consider whether your supporting information needs to be searchable and/or editable, and choose the most suitable format accordingly. See the Figure Guidelines for more detail about our requirements for multimedia files and the file formats we accept.
Are You Ready to Submit Your Manuscript?
We have provided an author checklist to help you prepare your materials for submission and to make the online submission process as straightforward as possible. Please take the time to look through the list before submitting your article.
If you are submitting a revised manuscript, you will have been given substantial guidance by the editors. We have provided a checklist for revised manuscripts.
Electronic Submission
Detailed instructions for submission can be found on the PLoS Neglected Tropical Diseases Manuscript Submission and Peer Review Web site. Files are uploaded individually and are combined into a single PDF file, which must be approved by the author at the end of the submission process.
Text files can be submitted in DOC or RTF format. Please convert LaTeX files to one of the acceptable formats.
Graphics files can only be submitted in EPS or TIF format. If possible, please label all figures with a standard font such as Arial or Times New Roman. Please read the Guidelines for Figure Preparation before submitting figures.
Articles for the Magazine Section
In addition to publishing original research papers, PLoS Neglected Tropical Diseases will have an engaging magazine section with dedicated editors. Articles in the magazine section will mostly be commissioned, but we welcome your ideas for articles. If you would like to write a magazine-section article, please submit a presubmission inquiry or a full submission. If you wish to submit a full submission, please note that you must submit your manuscript as a "Research Article" - please kindly make a note in the "Comments" box of your submission form and we will change the article categorization for you.
Word counts for magazine-section articles are given in the descriptions below. Very long documents can be hosted as supplementary files (Supporting Information) with the magazine-section articles.
Editorial
These 600- to 800-word articles are written in-house by the Editor-in-Chief or a member of the Editorial Board.
Viewpoints
Viewpoints are opinion pieces grounded in evidence. The word limit is 1,500 words. Authors are encouraged to cite up to 15 references in support of their key assertions, and to use a logical structure for their piece. We encourage all authors to include a display item (a figure, photo, or illustration), which will be published under the Creative Commons Attribution License. Please see Guidelines for Table and Figure Preparation.
Debate
The Debate highlights topical, emerging, or controversial issues in the NTDs field, such as controversies about the best treatment or prevention approach. Debates will be commissioned from two or more authors with differing points of view. Each author has up to 800 words and 10 references to outline their initial viewpoint, and then 400 words and 5 references to respond to the opposing viewpoint. We encourage each author to include a display item (a figure, photo, or illustration), which will be published under the Creative Commons Attribution License. Please see Guidelines for Table and Figure Preparation.
Policy Platform
These articles provide a platform to discuss specific policies that could improve the lives of those at risk of, or affected by, the NTDs. New and specific policy proposals that arise from high-level national or international meetings will be considered for this section, but we will not publish traditional "meeting reports." These articles are usually 2,000 words, with up to 25 references. In very exceptional circumstances (i.e., when the article is of particular public-health importance), we will give authors a higher word limit, but this must be negotiated with the editors ahead of writing the article. We encourage all authors to include 3-5 display items (figures, photos, illustrations), which will be published under the Creative Commons Attribution License. Please see Guidelines for Table and Figure Preparation.
Review
In these articles, the author reviews the best available evidence on a topic relevant to the NTDs community. Authors must include a short abstract and a brief "Methods" section that tells readers how they searched and appraised the literature in preparing the review. The word limit is 3,000 words, with 50-80 references. In very exceptional circumstances (i.e., when the article is of particular public-health importance), we will give authors a higher word limit, but this must be negotiated with the editors ahead of writing the article. Authors must include two boxes:
A box that lists the 3-5 key learning points in their review
A box that lists the 5 key papers in the field
We encourage all authors to include 3-5 display items (figures, tables, photos, or illustrations), which will be published under the Creative Commons Attribution License. Please see Guidelines for Table and Figure Preparation.
Expert Commentary
In this article, we commission an expert to comment on a Research Article published in PLoS Neglected Tropical Diseases. The author will usually be the Academic Editor who oversaw the peer review of the Research Article, or one of the peer reviewers. The word limit is 1,000 words, with up to 15 references. We may also commission expert commentaries on research papers in other journals, provided that these papers are freely available online. We encourage all authors to include a display item (a figure, photo, or illustration), which will be published under the Creative Commons Attribution License. Please see Guidelines for Table and Figure Preparation.
From Innovation to Application
These short articles (1,000 words, 10 references) discuss new technologies, such as drugs, vaccines, and diagnostics, relevant to NTDs. Authors are asked to take an objective and critical view, and they should include a box that lists up to 3 advantages and 3 disadvantages of the new technology. We will ask for a second box or table depending on what kind of tool is described (for example, if the tool is a new diagnostic tool, we will ask for a table that gives the sensitivity and specificity of the new tool compared with the existing gold standard). Authors with competing interests related to the technology (e.g., financial ties) will not be allowed to write for this section. We encourage all authors to include a display item (a figure, photo, or illustration), which will be published under the Creative Commons Attribution License. Please see Guidelines for Table and Figure Preparation.
Symposium
This section has four sub-types:
Laboratory Symposium
Clinical Symposium
Control Symposium
Social, Cultural, Economic Symposium
In each case, the article begins by presenting a short "real-world" problem or challenge, and then uses this problem as the basis for an educational piece of up to 2,000 words, with 25 references. Further details for each type of symposium are given below:
Laboratory Symposium
These are problem-based learning articles, up to 2,000 words long. They begin with a description of a "real-world" problem (not a hypothetical one), which will be in the form of a set of laboratory results (e.g., microscopy, hematology results, drug susceptibility tests, alternative diagnoses) that are interesting, illuminating, or unusual and that will appeal to the journal’s wider audience. This is then followed by a tutorial in the form of a series of questions and answers that help readers make sense of, and learn from, this set of laboratory results. Authors must include a box that lists the 3-5 key learning points of the article. We cannot publish any data that would identify a patient unless we have the patient’s written consent, using our consent form (also available in French, Portuguese, and Spanish). We encourage all authors to include 3-5 display items (figures, photos, illustrations), which will be published under the Creative Commons Attribution License. Please see Guidelines for Table and Figure Preparation.
Clinical Symposium
There are two types of article that we will publish in the Clinical Symposium section:
Case-based learning articles, up to 2,000 words long. These begin with a description of how the patient presented, under the heading "Description of Case." This is then followed by a tutorial in the form of clinical questions and answers interspersed with further details of the case. An example of how this type of article is structured is at http://dx.doi.org/10.1371/journal.pmed.0020229. The title should succinctly describe the problem but should not reveal the diagnosis (e.g., "A 17-Year-Old with Gradual Onset Blindness" or "A 45-Year-Old Woman with Chronic Itching"). Authors must obtain written consent from the patient using our consent form (also available in French, Portuguese, and Spanish). Authors must include a box that lists the 3-5 key learning points of the article. We strongly recommend that authors include examples of the patient’s investigations (e.g., imaging, electrocardiograms, a video of the patient’s clinical signs), all of which will be published under the Creative Commons Attribution License.
Case reports, up to 1,000 words long. Case reports will not be commissioned. To inquire about submitting a case report, please e-mail plosntds [at] plos.org. Authors must obtain written consent from the patient using our consent form (also available in French, Portuguese, and Spanish). We will publish only cases that contain a valuable lesson or clinical reminder, and authors must include a box that lists the 3-5 key learning points of the article. An example of how case reports in PLoS Neglected Tropical Diseases should be structured is at http://dx.doi.org/doi:10.1371/journal.pmed.0010015. We strongly recommend that authors include examples of the patient’s investigations (e.g., imaging, electrocardiograms, a video of the patient’s clinical signs), all of which will be published under the Creative Commons Attribution License. Please see Guidelines for Table and Figure Preparation.
Control Symposium
These are problem-based learning articles, up to 2,000 words long. They begin with a description of a "real-world" disease control challenge (i.e., at the community level, not the individual level). This is then followed by a tutorial in the form of a series of questions and answers that help readers understand how to tackle this type of control problem. Authors must include a box that lists the 3-5 key learning points of the article. We cannot publish any data that would identify a patient unless we have the patient’s written consent, using our consent form (also available in French, Portuguese, and Spanish). We encourage all authors to include 3-5 display items (figures, photos, illustrations), which will be published under the Creative Commons Attribution License. Please see Guidelines for Table and Figure Preparation.
Social, Cultural, Economic Symposium
These are problem-based learning articles, up to 2,000 words long. They begin with a description of a "real-world" scenario with social, cultural, or economic implications. Examples include: the case of a woman with lymphatic filariasis whose family is too afraid to touch her; an African community that declines to allow mass drug administration because of culturally based suspicions of "Western" medicine; the case of a man blinded by trachoma or onchocerciasis who can no longer provide for his family; or the case of a boy with chronic hookworm infection with chronic stunting and cognitive difficulties. The description of the scenario is then followed by a tutorial in the form of a series of questions and answers that help readers understand how to approach such social, cultural, and economic concerns. Authors must include a box that lists the 3-5 key learning points of the article. We cannot publish any data that would identify a patient unless we have the patient’s written consent, using our consent form (also available in French, Portuguese, and Spanish). We encourage all authors to include 3-5 display items (figures, photos, illustrations), which will be published under the Creative Commons Attribution License. Please see Guidelines for Table and Figure Preparation.
Historical Profiles and Perspectives
These articles look back in history to discuss a notable figure or a control program that worked or failed. Articles should be up to 1,500 words, with 15 references. We encourage all authors to include a display item (figure, photo, illustration), which will be published under the Creative Commons Attribution License. Please see Guidelines for Table and Figure Preparation.
Interviews
These articles are up to 1,000 words long, and the author interviews a person who has made an important contribution to the fight against NTDs. We encourage the author to include a photo of the interviewee, which will be published under the Creative Commons Attribution License.
Editorial Board
Editors-in-Chief
Peter Hotez
The George Washington University,
Washington DC, USA
Serap Aksoy
Yale School of Public Health,
New Haven, Connecticut, USA
Deputy Editors
Jeff Bethony
George Washington University Medical Center,
Washington DC, USA
Paul Brindley
George Washington University Medical Center,
Washington DC, USA
Simon Brooker
London School of Hygiene and Tropical Medicine,
London, UK
Charles King
Case Western Reserve University,
Cleveland, Ohio, USA
Albert Ko
Yale School of Public Health, Yale School of Medicine,
New Haven, Connecticut, USA
A. Desiree La Beaud
Case Western Reserve University,
Cleveland, Ohio, USA
Mike Lehane
Liverpool School of Tropical Medicine,
Liverpool, UK
Sara Lustigman
Lindsley F. Kimball Research Institute,
New York Blood Center,
New York, New York, USA
Photini Sinnis
New York University School of Medicine,
New York, New York, USA
Pamela Small
University of Tennessee,
Knoxville, Tennessee, USA
Juerg Utzinger
Swiss Tropical Institute,
Basel, Switzerland
Associate Editors
Oladele B. Akogun
Federal University of Technology,
Yola, Nigeria
Judith Allen
University of Edinburgh,
Edinburgh, UK
Roberto Barrera
Centers for Disease Control and Prevention,
San Juan, Puerto Rico
Maria-Gloria Basáñez
Imperial College London,
London, UK
Paul Bates
Lancaster University,
Lancaster, UK
Daniel G. Bausch
Tulane School of Public Health and Tropical Medicine,
New Orleans, Louisiana, USA
Zvi Bentwich
Center for Infectious Diseases and AIDS, Ben Gurion University,
Beer Sheba, Israel
Alok Bhattacharya
Jawaharlal Nehru University,
New Delhi, India
David Blair
James Cook University,
Townsville, Australia
Marleen Boelaert
Institute of Tropical Medicine,
Antwerp, Belgium
Maria Elena Bottazzi
The George Washington University,
Washington DC, USA
Pierre Buffet
Institut Pasteur,
Paris, France
Philippe Büscher
Institute of Tropical Medicine Antwerp,
Antwerp, Belgium
Alejandro Buschiazzo
Pasteur Institute of Montevideo,
Montevideo, Uruguay
Laurence U. Buxbaum
University of Pennsylvania School of Medicine,
Philadelphia, Pennsylvania, USA
Michael Cappello
Yale University,
New Haven, Connecticut, USA
Hélène Carabin
University of Oklahoma Health Sciences Center,
Oklahoma City, Oklahoma, USA
Jane Carlton
New York University School of Medicine,
New York, New York, USA
Edgar Carvalho
Universidade Federal da Bahia Salvador,
Bahia, Brazil
Marilia Sá Carvalho
Oswaldo Cruz Foundation,
Rio de Janeiro, Brazil
Cheng-Chen Chen
National Yang-Ming University,
Taipei, Taiwan
Rita Colwell
University of Maryland,
College Park Maryland
Rodrigo Correa-Oliveira
FIOCRUZ,
Rio de Janeiro, Brazil,
Belo Horizonte, Brazil
John P. Dalton
McGill University,
Montreal, Canada
Stephen J. Davies
Uniformed Services University of the Health Sciences,
Bethesda, Maryland, USA
David Diemert
Human Hookworm Vaccine Initiative,
Sabin Vaccine Institute,
Washington DC, USA
Rhoel R. Dinglasan
Johns Hopkins Bloomberg School of Public Health,
Baltimore, MD, USA
Daniel Eichinger
New York University School of Medicine,
New York, New York, USA
Dirk Engels
The World Health Organization,
Geneva, Switzerland
Christian Engwerda
The Queensland Institute of Medical Research,
Brisbane, Australia
Ana Flisser
Universidad Nacional Autónoma de México,
Mexico City, Mexico
Carlos Franco-Paredes
Emory School of Medicine, Atlanta,
Hospital Infantil de Mexico Federico Gomez, Mexico City
Amadou Garba
Ministere de la Sante Publique,
Niamey, Niger
Hector H. Garcia
Universidad Peruana Cayetano Heredia,
Lima, Peru
Ricardo T. Gazzinelli
University of Massachusetts Medical School,
Worcester, Massachusetts, USA
Timothy Geary
McGill University,
Montreal, Canada
Thomas Geisbert
Boston University School of Medicine,
Boston, Massachusetts, USA
Elodie Ghedin
University of Pittsburgh,
Pittsburgh, Pennsylvania, USA
Duane Gubler
Asia-Pacific Institute of Tropical Medicine and Infectious Diseases,
Honolulu, Hawaii, USA
Ricardo E. Gurtler
Universidad de Buenos Aires,
Buenos Aires, Argentina
Maria Guzman
Institute of Tropical Medicine Pedro Kouri,
Habana, Cuba
John Gyapong
Health Research Unit,
Ghana Health Service,
Accra, Ghana
Theresa Gyorkos
McGill University,
Montreal, Canada
Scott Halstead
Pediatric Dengue Vaccine Initiative,
Seoul, Korea
Eva Harris
University of California, Berkeley,
Berkeley, California, USA
Kenji Hirayama
Nagasaki University,
Nagasaki, Japan
Jorge Huete-Pérez
Universidad Centroamericana,
Managua, Nicaragua
Akira Ito
Asahikawa Medical College,
Asahikawa, Japan
Charles Jaffe
Hadassah Medical School,
Hebrew University,
Jerusalem, Israel
Anthony James
University of California, Irvine,
Irvine, California, USA
Malcolm K. Jones
The Queensland Institute of Medical Research,
Brisbane, Australia
Narcis Kabatereine
Ministry of Health,
Kampala, Uganda
Shaden Kamhawi
LMVR/NIAID/NIH,
Rockville, Maryland, USA
Gagandeep Kang
Christian Medical College,
Vellore, India
Jennifer Keiser
Swiss Tropical Institute,
Basel, Switzerland
Ben L. Kelly
Louisiana State University Health Sciences Center,
New Orleans, Louisiana, USA
Rebekah Kent
Centers for Disease Control and Prevention,
Fort Collins, Colorado, USA
Kiyoshi Kita
The University of Tokyo,
Tokyo, Japan
Pattamaporn Kittayapong
Mahidol University,
Bangkok, Thailand
Matty Knight
Biomedical Research Institute,
Rockville, Maryland, USA
David Lalloo
Liverpool School of Tropical Medicine,
Liverpool, UK
Patrick Lammie
Centers for Disease Control and Prevention,
Atlanta, Georgia, USA
Diane Lockwood
London School of Hygiene and Tropical Medicine,
London, UK
Anuradha Lohia
Bose Institute,
Kolkata, India
Benedito A. Lopes da Fonseca
Universidade de São Paulo,
São Paulo, Brazil
Hechmi Louzir
Institute Pasteur de Tunis,
Tunis, Tunisia
Sheila Lukehart
University of Washington,
Seattle, Washington, USA
Kirsten E. Lyke
Center for Vaccine Development,
University of Maryland,
Baltimore, Maryland, USA
Andrew MacDonald
University of Edinburgh,
Edinburgh, Scotland
Charles Mackenzie
Michigan State University,
East Lansing, MI, USA
Elizabeth A. L. Martins
Instituto Butantan,
Sao Paulo, Brazil
Daniel Masiga
International Centre of Insect Physiology and Ecology,
Nairobi, Kenya
Greg Matlashewski
McGill University,
Montreal, Canada
James McCarthy
The Queensland Institute of Medical Research,
Brisbane, Australia
James H. McKerrow
University of California, San Francisco,
San Francisco, California, USA
Diane McMahon-Pratt
Yale University,
New Haven, Connecticut, USA
Genevieve Milon
Institut Pasteur,
Paris, France
Jorge Motta
Instituto Conmemorativo Gorgas de Estudios de la Salud,
Panama City, Panama
Dunstan Mukoko
Ministry of Health,
Nairobi, Kenya
Kosta Y. Mumcuoglu
Hadassah Medical School,
Hebrew University,
Jerusalem, Israel
Joseph Ndung'u
Foundation for Innovative New Diagnostics (FIND),
Cointrin, Switzerland
Richard Ndyomugyenyi
Vector Control Division,
Ministry of Health,
Kampala, Uganda
Jeremia Ngondi
University of Cambridge,
Cambridge, UK
Sergio Costa Oliveira
Federal University of Minas Gerais,
Minas Gerais, Brazil
Kenneth Olson
Colorado State University,
Fort Collins, CO, USA
Scott O'Neill
The University of Queensland,
Brisbane, Australia
Mehmet Ali Özcel
Medical Faculty of Ege University,
Izmir, Turkey
Sharon J. Peacock
Mahidol University,
Bangkok, Thailand
Richard Phillips
Kwame Nkrumah University of Science and Technology/ Komfo Anokye Teaching Hospital, Department of Medicine,
Kumasi, Ghana
Mathieu Picardeau
Institut Pasteur,
Paris, France
Ann Powers
Centers for Disease Control and Prevention,
Fort Collins, CO, USA
Roger Prichard
McGill University,
Montreal, Canada
Didier Raoult
Université de la Méditerranée,
Marseille, France
Jayne Raper
New York University School of Medicine,
New York, New York, USA
Giovanna Raso
The Queensland Institute of Medical Research,
Brisbane, Australia
Rebeca Rico-Hesse
Southwest Foundation for Biomedical Research,
San Antonio, Texas, USA
Ana Rodriguez
New York University School of Medicine,
New York, New York, USA
Alan Rothman
University of Massachusetts Medical School,
Worcester, Massachusetts, USA
Craig Roy
Yale University School of Medicine,
New Haven, Connecticut, USA
Edward Ryan
Harvard University and Massachusetts General Hospital,
Boston, Massachusetts, USA
Rosemary C. Sang
Centre for Virus Research,
Nairobi, Kenya
Helton da Costa Santiago
George Washington School of Medicine,
Washington DC, USA
José Ignacio Santos
Hospital Infantil de Mexico,
Mexico City, Mexico
Julius Schachter
University of California, San Francisco,
San Francisco, California, USA
Edmund Seto
University of California, Berkeley,
Berkeley, California, USA
Nilanthi de Silva
University of Kelaniya,
Dalugama, Sri Lanka
Gary Simon
The George Washington University,
Washington DC, USA
Sunit K. Singh
Centre for Cellular and Molecular Biology (CCMB),
Hyderabad, India
Philippe Solano
CIRDES/IRD UMR 177 IRD-CIRAD ,
Bobo-Dioulasso, Burkina Faso
Banchob Sripa
Khon Kaen University,
Khon Kaen, Thailand
Louis-Albert Tchuem Tchuenté
Centre for Schistosomiasis and Parasitology,
University of Yaoundé,
Yaoundé, Cameroon
Robert Tesh
University of Texas Medical Branch,
Galveston, Texas, USA
Yara M. Traub-Csekö
Laboratório de Biologia Molecular de Parasitas e Vetores, Instituto Oswaldo Cruz
Fiocruz, Rio de Janeiro, Brazil
Christian Tschudi
Yale School of Public Health,
New Haven, Connecticut, USA
Mike Turell
USAMRIID,
Fort Detrick, Maryland, USA
Jesus Valenzuela
National Institutes of Health,
Bethesda, Maryland, USA
Joseph M. Vinetz
University of California San Diego School of Medicine,
La Jolla, California, USA
David H. Walker
University of Texas Medical Branch,
Galveston, Texas, USA
Judd Walson
University of Washington,
Seattle, Washington, USA
Joanne Webster
Imperial College London,
London, UK
Maria Yazdanbakhsh
Leiden University Medical Center,
Leiden, Netherlands
Xiao-Nong Zhou
National Institute of Parasitic Diseases,
Chinese Center for Disease Control and Prevention,
Shanghai, China
Jakob Zinsstag
Swiss Tropical Institute,
Basel, Switzerland
Editorial Advisors
Uche Amazigo
African Programme for Onchocerciasis Control,
The World Health Organization,
Ouagadougou, Burkina Faso
Daniel G. Colley
University of Georgia,
Athens, Georgia, USA
Pierre Druilhe
Institut Pasteur,
Paris, France
Richard Feachem
The Global Fund to Fight AIDS, Tuberculosis, and Malaria,
Geneva, Switzerland
Alan Fenwick
Imperial College London,
London, UK
Paul Fine
London School of Hygiene and Tropical Medicine,
London, UK
Victoria Hale
Institute for OneWorld Health,
San Francisco, California, USA
Paul Hunt
The Human Rights Centre, University of Essex,
Essex, UK
Alex Loukas
The Queensland Institute of Medical Research,
Brisbane, Australia
Santiago Mas-Coma
Departamento de Parasitologia, Universidad de Valencia,
Valencia, Spain
Don McManus
The Queensland Institute of Medical Research,
Brisbane, Australia
David Molyneux
Liverpool School of Tropical Medicine,
Liverpool, UK
Carlos Morel
FIOCRUZ,
Rio de Janeiro, Brazil
James Mwanzia
Prevention and Control of Communicable Diseases, World Health Organization,
Brazzaville, Republic of Congo
G. Richard Olds
Medical College of Wisconsin,
Milwaukee, Wisconsin, USA
Eric A. Ottesen
Task Force for Child Survival and Development, &
Rollins School of Public Health, Emory University,
Atlanta, Georgia, USA
Frank Richards, Jr.
The Carter Center,
Atlanta, Georgia, USA
Lee W. Riley
University of California, Berkeley,
Berkeley, California, USA
Laura C. Rodrigues
London School of Hygiene and Tropical Medicine,
London, UK
Jeffrey D. Sachs
The Earth Institute at Columbia University,
New York, New York, USA
Nancy Gore Saravia
Centro Internacional de Entrenamiento e Investigaciones Medicas,
Cali, Colombia
Lorenzo Savioli
The World Health Organization,
Geneva, Switzerland
Terrence Spithill
Institute of Parasitology, McGill University,
Montreal, Canada
Ken Stuart
Seattle Biomedical Research Institute,
Seattle, Washington, USA
Marcel Tanner
Swiss Tropical Institute,
Basel, Switzerland
Thomas R. Unnasch
The University of Alabama at Birmingham,
Birmingham, Alabama, USA
Gary Weil
Washington University,
St. Louis, Missouri, USA
| 
刊名字顺( Alphabetical List of Journals):
返回页首 